Access to anti-retroviral drugs, female in Arab World
Arab World: Access to anti-retroviral drugs, female was 48.4% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Arab World, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Arab World stood at 48.4%.
Compared with earlier readings it is down 0.1% on the previous year and up 88.2% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Arab World peaked at 48.4% in 2023 and was at its lowest, 1.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Arab World, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 1.0% | — |
| 2001 | 1.2% | +19.3% |
| 2002 | 1.4% | +14.6% |
| 2003 | 2.5% | +80.0% |
| 2004 | 2.8% | +9.5% |
| 2005 | 4.7% | +68.1% |
| 2006 | 6.2% | +32.9% |
| 2007 | 7.8% | +24.6% |
| 2008 | 8.4% | +8.5% |
| 2009 | 11.1% | +32.3% |
| 2010 | 13.2% | +18.8% |
| 2011 | 15.6% | +17.4% |
| 2012 | 18.5% | +18.6% |
| 2013 | 22.4% | +21.6% |
| 2014 | 25.7% | +14.5% |
| 2015 | 29.1% | +13.1% |
| 2016 | 33.4% | +14.9% |
| 2017 | 38.0% | +13.7% |
| 2018 | 41.2% | +8.6% |
| 2019 | 42.8% | +3.7% |
| 2020 | 44.2% | +3.4% |
| 2021 | 46.6% | +5.4% |
| 2022 | 46.8% | +0.3% |
| 2023 | 48.4% | +3.6% |
| 2024 | 48.4% | -0.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.7% | 1.0% | 11.1% | 10 |
| 2010s | 28.0% | 13.2% | 42.8% | 10 |
| 2020s | 46.9% | 44.2% | 48.4% | 5 |
Countries ranked near Arab World
More gender data for Arab World
- Labor force, female 27.41 million (2025)
- Labor force, female, per capita 0.0545 units per person (2025)
- Labor force, female, per unit of GDP 0 units per US$ of GDP (2025)
- Labor force, female, annual growth rate 2.68 % change on previous year (2025)
- Labor force, female, per square kilometre 2.02 units per square kilometre (2023)
- Incidence of HIV, ages 15-49, female 0.092 per 1,000 uninfected female population ages 15-49 (2024)
- Incidence of HIV, ages 15-49, male 0.1271 per 1,000 uninfected male population ages 15-49 (2024)
- Incidence of HIV, ages 15-24, female 0.0887 per 1,000 uninfected female population ages 15-24 (2024)
- Incidence of HIV, ages 15-24, male 0.1065 per 1,000 uninfected male population ages 15-24 (2024)
- Ratio of female to male youth unemployment rate (% ages 15-24) 211.1% (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Arab World?
- Access to anti-retroviral drugs, female in Arab World was 48.4% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Arab World?
- The highest recorded value was 48.4% in 2023.
- What is the lowest access to anti-retroviral drugs, female recorded in Arab World?
- The lowest recorded value was 1.0% in 2000.
- How does Arab World rank for access to anti-retroviral drugs, female?
- Arab World ranks 16th out of 19 groups with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Arab World?
- Over the last ten years it is up 88.2%. The long-run trend across the full record is volatile.
- Where does this Arab World data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.